Pharmacists’ influence on adverse reactions to warfarin: a randomised controlled trial in elderly rural patients
- 64 Downloads
Background Adverse reactions to warfarin may be serious and can lead to hospitalisation or death. Minimising the risk of adverse drug reactions through the intervention of community pharmacists is important for patients receiving warfarin, especially for elderly (≥ 65 years) patients living in rural areas. Objective To evaluate the impact of an intervention by community pharmacists on the risk of adverse drug reactions in elderly rural patients receiving warfarin. Setting: A community pharmacy in a rural area of Croatia. Method We conducted a prospective randomised trial. Eligible patients were recruited at the pharmacy and randomised into one of two groups. The participants were followed up every month for 6 months. Main outcome measure: The incidence and type of adverse drug reactions caused by warfarin and the time-to-event. Results In total, 140 patients were randomized and 131 patients completed the study; 65 patients were in the intervention group. The median age of patients was 73 years of age. The cumulative incidence of adverse drug reactions was significantly lower in the intervention group (6-months rate 29% vs. 85% for intervention and control, respectively; hazard ratio = 0.17, p < 0.001) than in the control group. Factors multivariately associated with the development of adverse drug reactions related to warfarin (p < 0.05) were the absence of pharmaceutical intervention, higher time in therapeutic range, change of warfarin dose, changes in dietary vitamin K intake, and marital status other than married. Conclusion Overall, the pharmacist’s intervention significantly prolonged the time to occurrence of adverse drug reactions and reduced their incidence.
KeywordsAdverse drug reactions Croatia Elderly Pharmacists’ intervention Rural population Warfarin
This study is a part of the Ph.D. thesis of the first author. The authors would like to acknowledge all the general practitioners responsible for the study participants for the provision of the required data.
This study was self-funded.
Conflicts of interest
The authors declare that they have no conflicts of interest.
- 10.Brezzi M, Dijkstra L, Ruiz V. OECD extended regional typology: the economic performance of remote rural regions. OECD Regional Development Working Papers, 2011/06, OECD Publishing. http://dx.doi.org/10.1787/5kg6z83tw7f4-en Accessed 15 May 2019.
- 11.Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, et al. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation. 2008;118:2029–37.CrossRefGoogle Scholar
- 24.Tschol N, Lai DK, Tilley JA, Wong H, Brown GR. Comparison of physician- and pharmacist-managed warfarin sodium treatment in open heart surgery patients. Can J Cardiol. 2003;19(12):1413–7.Google Scholar
- 30.Harper P, Mcmichael I, Griffiths D, Harper J, Hill C. The community pharmacy-based anticoagulation management service achieves a consistently high standard of anticoagulant care. N Z Med J. 2015;128(1422):31–41.Google Scholar
- 33.Costa GLDB, Lamego RM, Colosimo EA, Valacio RA, Moreira MDCV. Identifying potential predictors of high-quality oral anticoagulation assessed by time in therapeutic international normalized ratio range: a prospective, long-term, single-center, observational study. Clin Ther. 2012;34(7):1511–20.CrossRefGoogle Scholar
- 36.Urbonas G, Valius L, Šakalytė G, Petniūnas K, Petniūnienė I. The quality of anticoagulation therapy among warfarin-treated patients with atrial fibrillation in a primary health care setting. Medicina (Kaunas). 2019;55(1):1–15.Google Scholar